Cargando…

Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine

Detalles Bibliográficos
Autores principales:	Karch, Christopher P, Matyas, Gary R, Burkhard, Peter, Beck, Zoltan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378949/ https://www.ncbi.nlm.nih.gov/pubmed/30815025 http://dx.doi.org/10.2217/fvl-2018-0174

Ejemplares similares

Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers
por: Ringe, Rajesh P., et al.
Publicado: (2017)

P20-08. Glycosylation: an important factor in Env diversity
por: Desaire, H, et al.
Publicado: (2009)

Native‐like Env trimers as a platform for HIV‐1 vaccine design
por: Sanders, Rogier W., et al.
Publicado: (2017)

Conformational study of quaternary epitope region of V1/V2 loop: influence of disulfide bonds and glycosylations
por: Gnanakaran, G, et al.
Publicado: (2012)

Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
por: Heß, Rebecca, et al.
Publicado: (2019)

Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
por: Yasmeen, Anila, et al.
Publicado: (2014)

Discrete partitioning of HIV-1 Env forms revealed by viral capture
por: Stieh, Daniel J., et al.
Publicado: (2015)

Structure dynamics of HIV-1 Env trimers on native virions engaged with living T cells
por: Carlon-Andres, Irene, et al.
Publicado: (2021)

Natively Unstructured Loops Differ from Other Loops
por: Schlessinger, Avner, et al.
Publicado: (2007)

Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen
por: Struwe, Weston B., et al.
Publicado: (2018)

Similarity of chemokines charge and the V3 domain of HIV-1 env protein.
por: Berkhout, B, et al.
Publicado: (1998)

Recombinant Env proteins that bind the quaternary-specific, V1/V2-directed PGT antibodies
por: Gorman, J, et al.
Publicado: (2012)

A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection
por: Silver, Zachary A., et al.
Publicado: (2019)

Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
por: Gorman, Jason, et al.
Publicado: (2015)

Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2
por: Rolland, Morgane, et al.
Publicado: (2012)

Trimeric HIV Env provides epitope occlusion mediated by hypervariable loops
por: Moscoso, Carlos G., et al.
Publicado: (2014)

Augmenting glycosylation‐directed folding pathways enhances the fidelity of HIV Env immunogen production in plants
por: Margolin, Emmanuel, et al.
Publicado: (2022)

Envés
por: Amara, Luigi, 1971-
Publicado: (2003)

HIV-1 Env DNA prime plus gp120 and gp70-V1V2 boosts induce high level of V1V2-specific IgG and ADCC responses and low level of Env-specific IgA response: implication for improving RV144 vaccine regimen
por: Wang, Qian, et al.
Publicado: (2017)

Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells
por: Zhou, Fuling, et al.
Publicado: (2016)

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge
por: Borggren, Marie, et al.
Publicado: (2011)

A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity
por: González-Feliciano, José A., et al.
Publicado: (2020)

Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
por: Suzuki, Tadaki
Publicado: (2015)

Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
por: Barnes, Christopher O., et al.
Publicado: (2018)

Measurement of Glycosylated Alpha-Fetoprotein Improves Diagnostic Power over the Native Form in Hepatocellular Carcinoma
por: Kim, Hyunsoo, et al.
Publicado: (2014)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
por: Ching, LK, et al.
Publicado: (2009)

Energetics of Opening for the Glycosylated and Unglycosylated Forms of the SARS-CoV-2 S-Protein Trimer
por: Tik Pang, Yui, et al.
Publicado: (2021)

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism
por: Jeanne, Nicolas, et al.
Publicado: (2015)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
por: Liao, L, et al.
Publicado: (2012)

Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer
por: Sarkar, Anita, et al.
Publicado: (2018)

Inhibition of N-linked Glycosylation by Tunicamycin May Contribute to The Treatment of SARS-CoV-2
por: Dawood, Ali Adel, et al.
Publicado: (2020)

DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies
por: Fuchs, JD, et al.
Publicado: (2012)

CCR5 interaction with HIV-1 Env contributes to Env-induced depletion of CD4 T cells in vitro and in vivo
por: Tsao, Li-Chung, et al.
Publicado: (2016)

Unlocking HIV-1 Env: implications for antibody attack
por: Richard, Jonathan, et al.
Publicado: (2017)

Generation of H9 T-cells stably expressing a membrane-bound form of the cytoplasmic tail of the Env-glycoprotein: lack of transcomplementation of defective HIV-1 virions encoding C-terminally truncated Env
por: Holtkotte, Denise, et al.
Publicado: (2006)

Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes
por: Upadhyay, Chitra, et al.
Publicado: (2020)

Structural characterization of HIV-1 Env heterotrimers bound to one or two CD4 receptors reveals intermediate Env conformations
por: Dam, Kim-Marie A., et al.
Publicado: (2023)

Specific Substitutions in Region V2 of gp120 env confer SHIV Neutralisation Resistance
por: Pisil, Yalcin, et al.
Publicado: (2020)

Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity
por: Schneider, Cosette G., et al.
Publicado: (2021)

Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody response
por: Bale, Shridhar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tjq3periq92usuhvc3rt2mkc8j